Protalix BioTherapeutics
PLX
#8648
Rank
A$0.12 B
Marketcap
$1.65
Share price
-4.35%
Change (1 day)
-38.07%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2023 (TTM): $0.15

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is $0.15. In 2022 the company made an earnings per share (EPS) of -$0.45 an increase over its 2021 EPS that were of -$0.93.

EPS history for Protalix BioTherapeutics from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.15-133.07%
2022-$0.45-51.61%
2021-$0.93342.86%
2020-$0.21-88.71%
2019-$1.86-34.74%
2018-$2.85-70.92%
2017-$9.802153.35%
2016-$0.43-146.77%
2015$0.93-287.88%
2014-$0.4910%
2013-$0.45130.77%
2012-$0.19-56.67%
2011-$0.45-46.43%
2010-$0.8436.59%
2009-$0.6132.26%
2008-$0.46-93.4%
2007-$7.051298.53%
2006-$0.50-96.59%
2005-$14.7919.32%
2004-$12.391552.65%
2003-$0.75-0%
2002-$0.75-50%
2001-$1.50233.33%
2000-$0.45-84.21%
1999-$2.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.96-740.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.94 1,860.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.79 1,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.00-2,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel